Form CORRESP - Correspondence:
SEC Accession No. 0001493152-24-038781
Filing Date
2024-09-30
Accepted
2024-09-30 16:05:17
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 16375
  Complete submission text file 0001493152-24-038781.txt   17645
Mailing Address 855 N. WOLFE STREET SUITE 601 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 601 BALTIMORE MD 21205 856-848-8698
TNF Pharmaceuticals, Inc. (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)